The levels of phosphorylated tau proteins (p‐tau 181, p‐tau 217, and p‐tau 231) indicate the amyloid plaque burden in AD; thus, these proteins may have utility for the diagnosis of CAA [7]. This evidence concerns the gene MAPT and amyloidosis.